Physician profile
Justin Regner
NPI 1710191739
$1,133.58
in general payments reported to CMS, 2019-2025
13 companies · $91.59 in 2025
The $91.59 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $11.42 · 2021: $292 · 2022: $470 · 2023: $99.25 · 2024: $46.34 · 2025: $91.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $399.78 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $277.02 | 2022 | |
| Intuitive Surgical, INC. | $99.25 | 2023 | Da Vinci Surgical System |
| Acell, INC. | $92.41 | 2019 | |
| Kerecis Limited | $76.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Atricure, INC. | $47.21 | 2022 | |
| Prytime Medical Devices, INC. | $30.21 | 2019 | |
| Edwards Lifesciences Corporation | $26.89 | 2024 | Hemosphere |
| Polynovo North America LLC | $19.67 | 2022 | |
| Ethicon US, LLC | $19.45 | 2024 | Echelon; Endopath |
| Integra Lifesciences Corporation | $18.68 | 2022 | |
| Haemonetics Corporation | $14.65 | 2025 | Teg6s Hemostasis System |
| Covidien LP | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Regner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.